Related Experiment Video
Updated: May 4, 2026
10:21
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
915
Systemic Reactive Amyloidosis Associated with Castleman's Disease
Vinaya Gaduputi1, Hassan Tariq1, Kanthi Badipatla1
1Department of Medicine, Bronx Lebanon Hospital Center, New York, N.Y., USA.
Case Reports in Gastroenterology
|December 19, 2013
Summary
This case study highlights a rare instance of secondary amyloidosis linked to Castleman
Area of Science:
- Medicine
- Pathology
- Oncology
Background:
- Castleman's disease is a rare lymphoproliferative disorder.
- Secondary amyloidosis involves amyloid deposition in organs due to chronic inflammation or other diseases.
Observation:
- A 51-year-old male presented with systemic symptoms including weakness, fatigue, weight loss, anorexia, and abdominal distension.
- Physical examination revealed a submandibular mass and tense ascites, indicative of multiorgan dysfunction.
- Ascitic fluid analysis showed spontaneous bacterial peritonitis, and biopsies confirmed Castleman's disease and amyloid deposition.
Findings:
- Biopsy of the submandibular mass confirmed angiofollicular lymph node hyperplasia, diagnostic of Castleman's disease.
- Liver and bone marrow biopsies revealed extensive amyloid protein deposition.
- The patient exhibited multiorgan dysfunction, including liver and kidney failure, and kappa light chain-restricted plasma cells.
Implications:
- This case underscores the rare association between Castleman's disease and secondary systemic amyloidosis.
- The patient's rapid decline and fatal outcome highlight the aggressive nature of untreated secondary amyloidosis.
- Early recognition and management strategies for this rare complication are crucial for improving patient outcomes.
Related Concept Videos
01:26Cushing Syndrome I: Introduction
36
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the...
36
01:19Cushing Syndrome II: Pathophysiology
24
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
24
03:03Amyloid Fibrils
10.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
10.2K
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
952
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952
01:19Hypersensitivity Reactions: Immune-Complex Reactions
269
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
269
01:01Hypersensitivity Reactions: Cytolytic Reactions
208
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
208